Literature DB >> 24194047

The relationships between the availability ofL-tryptophan to the brain, the spontaneous HPA-axis activity, and the HPA-axis responses to dexamethasone in depressed patients.

M Maes1, B Minner, E Suy.   

Abstract

The present study was conducted in order to investigate the negative relationships between measures of hypothalamic-pituitary-adrenal (HPA)-axis activity and the availability of L-tryptophan (L-TRP) to the brain in depressive patients. To this end we measured the following: plasma total L-TRP, the ratio of L-TRP to the sum of competing amino acids (CAA), free urinary cortisol (UFC) excretion in 24 hr urine samples, and the 8 a.m. postdexamethasone cortisol levels. We found that the availability of L-TRP to the brain was significantly negatively correlated with the postdexamethasone cortisol values. Cortisol nonsuppressors averaged significantly lower L-TRP and L-TRP/CAA values compared to suppressors. No significant relationship was established between the availability of L-TRP and UFC excretion. It is concluded that the availability of L-TRP is related to the actual alterations in cortisol induced by dexamethasone rather than with the spontaneous baseline HPA-axis activity.

Entities:  

Year:  1991        PMID: 24194047     DOI: 10.1007/BF00808091

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Relationship between the dexamethasone suppression test and the L-tryptophan/competing amino acids ratio in depression.

Authors:  M Maes; M De Ruyter; P Hobin; E Suy
Journal:  Psychiatry Res       Date:  1987-08       Impact factor: 3.222

2.  Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

Authors:  B J Carroll; G C Curtis; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1976-09

3.  Plasma tryptophan and five other amino acids in depressed and normal subjects.

Authors:  M K DeMyer; P A Shea; H C Hendrie; N N Yoshimura
Journal:  Arch Gen Psychiatry       Date:  1981-06

4.  The dexamethasone suppression test for melancholia.

Authors:  B J Carroll
Journal:  Br J Psychiatry       Date:  1982-03       Impact factor: 9.319

5.  Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.

Authors:  P E Stokes; P M Stoll; S H Koslow; J W Maas; J M Davis; A C Swann; E Robins
Journal:  Arch Gen Psychiatry       Date:  1984-03

6.  Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?

Authors:  M Berger; P Doerr; R Lund; T Bronisch; D von Zerssen
Journal:  Biol Psychiatry       Date:  1982-11       Impact factor: 13.382

7.  Resistance to inhibiting effect of dexamethasone in patients with endogenous depression.

Authors:  J L Nuller; M N Ostroumova
Journal:  Acta Psychiatr Scand       Date:  1980-02       Impact factor: 6.392

8.  The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories.

Authors:  M Maes; M De Ruyter; P Hobin; E Suy
Journal:  J Affect Disord       Date:  1986 May-Jun       Impact factor: 4.839

  8 in total
  2 in total

Review 1.  Neuroinflammation and comorbidity of pain and depression.

Authors:  A K Walker; A Kavelaars; C J Heijnen; R Dantzer
Journal:  Pharmacol Rev       Date:  2013-12-11       Impact factor: 25.468

2.  Effects of acute tryptophan depletion on affective processing in first-degree relatives of depressive patients and controls after exposure to uncontrollable stress.

Authors:  Christine Firk; C Rob Markus
Journal:  Psychopharmacology (Berl)       Date:  2008-06-13       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.